PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
MetadataShow full item record
Other Language Versions
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.The information included in this note reflects the available evidence at the date of publication.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-10-19)The aim of this study was to map existing country policies and initiatives addressing population dietary sodium reduction in the Region of the Americas; to identify policy gaps following what is outlined in the World Health ...
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-03-05)This fact-sheet presents the results of the first study to take place in the Caribbean to examine the best performing front-of-package labeling (FOPL). It was conducted by the Ministry of Health and Wellness of Jamaica, ...
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-10-26)This publication presents the set of new and revised Pan American Health Organization (PAHO) Regional Sodium Reduction Targets 2021–2025 adopted by the PAHO Technical Advisory Group on Cardiovascular Disease Prevention ...